$MRNA news
The latest MRNA stock news: headlines, filings, AI summaries and sentiment for $MRNA, updated around the clock.
- Moderna Plans to Use Massachusetts Facility as Global Supply Hub for Cancer Vaccine
- MSCI Announces November Equity Index Changes Including Addition of Moderna to World Index
- Immunovant Reports Q2 2026 Financial Results and IMVT-1402 Clinical Data
- Roivant Sciences Reports Q2 2026 Results with LISRAYA Commercial Launch and Positive Clinical Data
- Moderna's Revenue Growth Driven by COVID Products Raises Valuation Concerns
- Moderna Upgrades 2026 Revenue Guidance Following Positive Phase 3 Cancer Vaccine Results
- Weekly Healthcare Market Update: Focus on Moderna, Pfizer, and CVS Health
- Healthcare Sector Reports Strong Earnings Performance with 96% EPS Beat Rate
- Technology Stocks Rebound Led by Semiconductor Sector Amid Positive Jobs Data
- Moderna, Inc. - 10-Q Filing
- Moderna Reports 29% Year-Over-Year Revenue Growth in Q3
- Moderna Reports Q3 2026 Profit Growth Driven by International Vaccine Sales
- Midday Market Update: Tech and Semiconductor Stocks Experience High Volatility
- Moderna Reports Third Quarter Profit Driven by Reduced R&D Spending
- Moderna Reports Surprise Third-Quarter Profit and Raises Full-Year Revenue Guidance
- Market Outlook: Strong Jobs Data, Tech Volatility, and Key Earnings Results
- Premarket Market Movers: Moderna, Cloudflare, and Airbnb Surge on Strong Earnings
- Moderna Shares Rise Following Q3 Earnings Beat and Increased Full-Year Guidance
- Moderna Raises Full-Year Revenue Growth Outlook Following Third Quarter Earnings Beat
- Moderna Exceeds Q3 Estimates and Raises 2026 Revenue Growth Guidance
- Moderna, Inc. - 8-K Filing
- Market Analysis: Nasdaq Enters Correction Territory Amid Big Tech Sell-off
- Key Corporate Earnings Reports Scheduled for Friday Pre-Market
- Moderna Scheduled to Report Q3 Earnings Amid Valuation Debates and Cancer Vaccine Developments
- Market Watch: Qualcomm-SpaceX Deal, Wendy's Privatization Rumors, and Energy Sector Trends
- Moderna's Ebola Vaccine Candidate Selected for WHO-Recommended Phase 2/3 Trial
- Moderna and Merck Face Manufacturing Challenges for Promising Personalized Cancer Vaccine
- Revvity Announces Quarterly Dividend of $0.07 Per Share
- Merck Reports Q3 Earnings Beat Driven by Keytruda and Gardasil Growth
- Axsome Therapeutics Shows Consistent Revenue Growth Amidst Moderna's Volatility
- AstraZeneca Explores Development of mRNA Cancer Vaccines
- Moderna Shares Decline Following William Blair Downgrade
- Moderna CEO Expresses Confidence in Personalized Cancer Vaccine Expansion Beyond Melanoma
- Midday Market Movers: Defense Upgrades, JetBlue Restructuring, and Major M&A Activity
- Premarket Market Movers: Verizon, Tesla, and Range Resources Lead Gains Amid M&A Activity
- ESMO Congress Highlights Oncology Breakthroughs Amid Market Volatility and Fed Uncertainty
- Moderna's mRNA Pipeline Expansion Drives Growth Potential Beyond COVID-19 Vaccines
- OpenAI Acquires Orchestra Bio to Enhance Biotech Capabilities
- Moderna Added to Nasdaq-100 Index, Impact on Investors
- Merck CEO Expresses Confidence in Improving Manufacturing Efficiency for Cancer Vaccine with Moderna
- Moderna's Market Cap Surpasses BioNTech by Over Three Times Amid Diverging Biotech Pipelines
- Healthcare Sector News Highlights Novavax, Moderna, and Becton Dickinson
- Moderna Stock Surges Over 14% on New Cancer Research Initiative
- Cystic Fibrosis: The Remaining 10% Still Lack Effective Treatments
- YieldMax MRNA Option Income Strategy ETF Announces Weekly Distribution of $0.7462
- Tempus AI Expands Cancer Therapy Collaboration with Moderna and Merck
- Stocks Making Significant Moves Midday: Marvell, Moderna, Lamb Weston and Others
- Novavax, Moderna trade flat as WHO downplays Russia's plague death
- Moderna Stock Surges Amid Positive Cancer Vaccine News
- Healthcare Stocks Underperform in September with XLV Down as Medtech Struggles